OPEN END TURBO LONG - HALEON Stock

Certificat

DE000MB0SKV9

Real-time Bid/Ask 05:38:03 2024-06-06 EDT
0.33 EUR / 0.34 EUR +15.52% Intraday chart for OPEN END TURBO LONG - HALEON
Current month+3.57%
1 month-17.14%
Date Price Change
24-06-05 0.29 0.00%
24-06-04 0.29 +7.41%
24-06-03 0.27 -3.57%
24-05-31 0.28 +3.70%
24-05-30 0.27 +15.88%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 06:41 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MB0SKV
ISINDE000MB0SKV9
Date issued 2022-11-17
Strike 302.9 p
Maturity Unlimited
Parity 1 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.139
Spread 0.01
Spread %2.94%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.278 GBP
Average target price
3.646 GBP
Spread / Average Target
+11.24%
Consensus